CASM potentiates STING-driven NFκB signaling in immune cells
Isis Benoit-Lizon(Inserm), Lionel Apétoh(Indiana University Health)
Cited by 0
Related Papers
Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?
|Annals of Oncology|2015|284
CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of T<sub>H</sub>1 and T<sub>H</sub>9 cells
|Journal for ImmunoTherapy of Cancer|2022|79
SOCS3 Transactivation by PPARγ Prevents IL-17–Driven Cancer Growth
|Cancer Research|2013|52
Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint Inhibitors
|Cells|2020|11
Etude du rôle de STING dans la biologie des lymphocytes T CD4 : application en immunothérapie anticancéreuse
|HAL (Le Centre pour la Communication Scientifique Directe)|2021|0